{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:03:21Z","timestamp":1785420201662,"version":"3.56.0"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023065","name":"State of California","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100023065","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/030sa3819","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Molecular testing and targeted therapeutics remain inequitably delivered among patients with cancer. In response, we refined a multilevel intervention directed at clinicians, payers, and patients to determine whether it could improve patient knowledge and receipt of precision cancer care more than an intervention directed at clinicians and payers alone. Methods: This patient-level randomized trial was conducted in a community oncology clinic among low income and racial and ethnic minority adults who were newly diagnosed with cancer or relapsed disease. We compared a two-level enhanced usual care intervention, in which patients received usual care, clinicians received annual precision medicine training, and payers eliminated prior authorization for molecular testing and targeted therapeutics (control group), with a three-level intervention, in which patients received enhanced usual care along with a patient-level 12 month precision medicine education component led by community health workers (intervention group). The primary outcome was precision medicine knowledge. Secondary outcomes were health-related quality of life (HRQOL), patient activation, satisfaction, acute care use, molecular testing, and targeted treatment. Results: Among 110 participants, the three-level intervention resulted in greater improvement in knowledge of precision medicine compared with the two-level control group (mean difference of 4.17, 95% CI of 2.33\u20137.48; p &lt; 0.001). Intervention participants also had greater patient activation and satisfaction with care, fewer emergency department visits and hospitalizations, and greater receipt of molecular testing and targeted therapy compared with patients in the control group. Conclusions: Multilevel interventions that include patient-level education can improve care delivery gaps. Trial Registration: clinicaltrials.gov, NCT04843332.<\/jats:p>","DOI":"10.3390\/cancers18081247","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:24:58Z","timestamp":1776176698000},"page":"1247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Community Health Workers and Precision Medicine: Results of a Randomized Clinical Trial on Patient Knowledge, Healthcare Use, and Evidence-Based Care"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-4732","authenticated-orcid":false,"given":"Emily H.","family":"Wood","sequence":"first","affiliation":[{"name":"Division of Oncology, Stanford University School of Medicine, Palo Alto, CA 94305, USA"},{"name":"Milken Institute School of Public Health, George Washington University, Washington, DC 20052, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesly Lopez","family":"Guzman","sequence":"additional","affiliation":[{"name":"Pacific Cancer Care, Monterey, CA 93940, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3056-2895","authenticated-orcid":false,"given":"Jajaira L.","family":"Reynaga","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of California, Santa Cruz, CA 95064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Villicana","sequence":"additional","affiliation":[{"name":"Independent Researcher, Monterey, CA 93940, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ysabel","family":"Duron","sequence":"additional","affiliation":[{"name":"The Latino Cancer Institute, San Jose, CA 95112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rosas","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, CA 94305, USA"},{"name":"Department of Medicine, Stanford University, Palo Alto, CA 94303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-5253","authenticated-orcid":false,"given":"Dale","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Cancer Patients Alliance, Pacific Grove, CA 93950, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary M.","family":"Koontz","sequence":"additional","affiliation":[{"name":"Pacific Cancer Care, Monterey, CA 93940, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-5762","authenticated-orcid":false,"given":"Manali I.","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Oncology, Stanford University School of Medicine, Palo Alto, CA 94305, USA"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40258-024-00901-4","article-title":"How is value defined in molecular testing in cancer? A scoping review","volume":"23","author":"Minhinnick","year":"2025","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_2","first-page":"305","article-title":"The current state of molecular testing in the treatment of patients with solid tumors, 2019","volume":"69","author":"Goldberg","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","unstructured":"American Cancer Society Medical and Editorial Content Team (2026, April 02). Cancer-Related Genomic Testing and Genetic Testing. Available online: https:\/\/www.cancer.org\/cancer\/understanding-cancer\/genes-and-cancer\/genomic-genetic-testing.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/NSG.0000000000000106","article-title":"Molecular testing and precision oncology: An overview","volume":"54","author":"Burkett","year":"2024","journal-title":"Nursing"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Seyhan, A.A. (2022). The Current State of Precision Medicine and Targeted-Cancer Therapies: Where Are We?. Drug Target Selection and Validation, Springer Nature.","DOI":"10.1007\/978-3-030-95895-4_7"},{"key":"ref_6","first-page":"1","article-title":"AI-Powered Precision Oncology: Computational Insights Redefining Therapeutic Landscapes","volume":"3","author":"Tippur","year":"2023","journal-title":"DHR Proc."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hoeben, A., Joosten, E.A., and van den Beuken-van Everdingen, M.H. (2021). Personalized medicine: Recent progress in cancer therapy. Cancers, 13.","DOI":"10.3390\/cancers13020242"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gambardella, V., Tarazona, N., Cejalvo, J.M., Lombardi, P., Huerta, M., Rosell\u00f3, S., Fleitas, T., Roda, D., and Cervantes, A. (2020). Personalized medicine: Recent progress in cancer therapy. Cancers, 12.","DOI":"10.3390\/cancers12041009"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semcancer.2020.07.009","article-title":"Precision medicine in non-small cell lung cancer: Current applications and future directions","volume":"84","author":"Yang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Curtin, M., and Dickerson, S.S. (2022). Precision medicine testing and disparities in health care for individuals with non-small cell lung cancer: A narrative review. Proceedings of the Oncology Nursing Forum, Oncology Nursing Society.","DOI":"10.1188\/22.ONF.257-272"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.21.02767","article-title":"Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion","volume":"40","author":"Chakravarty","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_12","unstructured":"National Cancer Institute (2025, March 30). Cancer Disparities, Available online: https:\/\/www.cancer.gov\/about-cancer\/understanding\/disparities."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.20.00642","article-title":"Cancer disparities and health equity: A policy statement from the American Society of Clinical Oncology","volume":"38","author":"Patel","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1200\/JCO.2021.39.15_suppl.9004","article-title":"Biomarker tissue journey among patients (pts) with untreated metastatic non-small cell lung cancer (mNSCLC) in the US Oncology Network community practices","volume":"39","author":"Robert","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ragavan, M.V., and Borno, H.T. (2023). The costs and inequities of precision medicine for patients with prostate cancer: A call to action. Proceedings of the Urologic Oncology: Seminars and Original Investigations, Elsevier.","DOI":"10.1016\/j.urolonc.2023.04.012"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/14737167.2023.2260563","article-title":"Precision medicine in Thoracic Oncology: Understanding disparities to tackle inequities in access","volume":"23","author":"Dienstmann","year":"2023","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"ref_18","unstructured":"Puckrein, G.A. (2021). Leading Health and Cancer Advocacy Groups Unite to Reduce Racial Disparities in Cancer Care, The ASCO Post."},{"key":"ref_19","first-page":"S2","article-title":"Addressing disparities in cancer care and incorporating precision medicine for minority populations","volume":"115","author":"Winn","year":"2023","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2021.04.025","article-title":"Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance","volume":"162","author":"Gamble","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s43018-023-00568-1","article-title":"Understanding inequities in precision oncology diagnostics","volume":"4","author":"Dutta","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e473930","DOI":"10.1200\/EDBK-25-473930","article-title":"Global oncology: Tackling disparities and promoting innovations in low-and middle-income countries","volume":"45","author":"Asirwa","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41431-024-01622-x","article-title":"Genomic testing in low-and middle-income countries (LMIC)","volume":"32","author":"Girisha","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Drake, T.M., Knight, S.R., Harrison, E.M., and S\u00f8reide, K. (2018). Global inequities in precision medicine and molecular cancer research. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00346"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1200\/JCO.2021.39.15_suppl.9005","article-title":"Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC)","volume":"39","author":"Bruno","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_26","first-page":"76","article-title":"Exploring cancer care needs for Latinx adults: A qualitative evaluation","volume":"31","author":"Rodriguez","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_27","unstructured":"Centers for Disease Control and Prevention (2026, March 01). What Is Health Literacy?, Available online: https:\/\/www.cdc.gov\/health-literacy\/php\/about\/index.html."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Holden, C.E., Wheelwright, S., Harle, A., and Wagland, R. (2021). The role of health literacy in cancer care: A mixed studies systematic review. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259815"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cncr.33248","article-title":"What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata","volume":"127","author":"Durand","year":"2021","journal-title":"Cancer"},{"key":"ref_30","first-page":"518","article-title":"Effect of a Community Health Worker\u2013Led Intervention Among Low-Income and Minoritized Patients with Cancer: A Randomized Clinical Trial","volume":"41","author":"Patel","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15248399221096415","DOI":"10.1177\/15248399221096415","article-title":"A Community-Engaged Process for Adapting a Proven Community Health Worker Model to Integrate Precision Cancer Care Delivery for Low-income Latinx Adults with Cancer","volume":"24","author":"Wood","year":"2023","journal-title":"Health Promot. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106906","DOI":"10.1016\/j.cct.2022.106906","article-title":"Community health workers and precision medicine: A randomized controlled trial","volume":"121","author":"Rodriguez","year":"2022","journal-title":"Contemp. Clin. Trials"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100799","DOI":"10.1016\/j.tranon.2020.100799","article-title":"Development of the Patient Activation Measure (PAM): Conceptualizing and measuring activation in patients and consumers","volume":"13","author":"Davies","year":"2020","journal-title":"Transl. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS1601","article-title":"Addressing Latinx CANcer Care Equity (ALCANCE) randomized controlled trial: Precision medicine and community health workers","volume":"40","author":"Rodriguez","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_36","unstructured":"(2026, March 01). Functional Assessment of Cancer Therapy\u2014General. Available online: https:\/\/www.facit.org\/measures\/FACT-G."},{"key":"ref_37","unstructured":"(2026, March 01). Patient Activation Measure. Available online: https:\/\/www.insigniahealth.com\/pam\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1475-6773.2005.00438.x","article-title":"Development and testing of a short form of the patient activation measure","volume":"40","author":"Hibbard","year":"2005","journal-title":"Health Serv. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0272989X9601600114","article-title":"Patient satisfaction with health care decisions: The satisfaction with decision scale","volume":"16","author":"Kroll","year":"1996","journal-title":"Med. Decis. Mak."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jama.279.21.1709","article-title":"Relationship between cancer patients\u2019 predictions of prognosis and their treatment preferences","volume":"279","author":"Weeks","year":"1998","journal-title":"JAMA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10810730.2014.943377","article-title":"Measurement of cancer health literacy and identification of patients with limited cancer health literacy","volume":"19","author":"Dumenci","year":"2014","journal-title":"J. Health Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_44","unstructured":"StataCorp (2019). Stata Statistical Software: Release 16, StataCorp LLC.. Available online: https:\/\/www.stata.com\/."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Wilkerson, A.D., Gentle, C.K., Ortega, C., and Al-Hilli, Z. (2024). Disparities in breast Cancer Care\u2014How factors related to Prevention, diagnosis, and Treatment Drive Inequity. Healthcare, 12.","DOI":"10.3390\/healthcare12040462"},{"key":"ref_46","first-page":"112","article-title":"American Cancer Society\u2019s report on the status of cancer disparities in the United States, 2021","volume":"72","author":"Islami","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1245\/s10434-021-11160-1","article-title":"Influence of race, insurance, rurality, and socioeconomic status on equity of lung and colorectal cancer care","volume":"29","author":"Leech","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2222220","DOI":"10.1001\/jamanetworkopen.2022.22220","article-title":"Structural racism and inequities in access to Medicaid-funded quality cancer care in the United States","volume":"5","author":"Alio","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1245\/s10434-021-10653-3","article-title":"Geographic disparities in oncologic treatment and outcomes: The urban\u2013rural divide","volume":"28","author":"Diaz","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zahnd, W.E., Murphy, C., Knoll, M., Benavidez, G.A., Day, K.R., Ranganathan, R., Luke, P., Zgodic, A., Shi, K., and Merrell, M.A. (2021). The intersection of rural residence and minority race\/ethnicity in cancer disparities in the United States. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18041384"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.pec.2017.03.019","article-title":"Does patient activation level affect the cancer patient journey?","volume":"100","author":"Hibbard","year":"2017","journal-title":"Patient Educ. Couns."},{"key":"ref_52","first-page":"191","article-title":"Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC)","volume":"31","author":"Vohra","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0738-3991(00)00166-X","article-title":"Measuring information needs among cancer patients","volume":"43","author":"Mesters","year":"2001","journal-title":"Patient Educ. Couns."},{"key":"ref_54","first-page":"e171","article-title":"Are health literacy and patient activation related to health outcomes in breast cancer patients?","volume":"5","author":"Kanu","year":"2021","journal-title":"HLRP Health Lit. Res. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaoncol.2024.1221","article-title":"Long-term engagement of patients with advanced cancer: Results from the EPAC randomized clinical trial","volume":"10","author":"Patel","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1200\/JOP.19.00152","article-title":"Lay health worker-led cancer symptom screening intervention and the effect on patient-reported satisfaction, health status, health care use, and total costs: Results from a tri-part collaboration","volume":"16","author":"Patel","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2021.39.15_suppl.1508","article-title":"The effect of a lay health worker intervention on acute care use, patient experiences and end-of-life care: Results from a randomized clinical trial","volume":"39","author":"Patel","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.23.01723","article-title":"Community Health Worker Navigation for Patients with Cancer: It Is Time to Scale up","volume":"42","author":"Adelson","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev-publhealth-071521-031648","article-title":"Community health worker integration with and effectiveness in health care and public health in the United States","volume":"44","author":"Knowles","year":"2023","journal-title":"Annu. Rev. Public Health"},{"key":"ref_60","first-page":"1139","article-title":"Effect of a Community Health Worker Intervention on Acute Care Use, Advance Care Planning, and Patient-Reported Outcomes Among Adults with Advanced Stages of Cancer: A Randomized Clinical Trial","volume":"8","author":"Patel","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaoncol.2018.2446","article-title":"Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients with Cancer: A Randomized Clinical Trial","volume":"4","author":"Patel","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00432-021-03579-6","article-title":"Cancer patients\u2019 perspective on shared decision-making and decision aids in oncology","volume":"147","author":"Josfeld","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1111\/jocn.15866","article-title":"Patient participation in shared decision-making in palliative care\u2013an integrative review","volume":"30","author":"Kuosmanen","year":"2021","journal-title":"J. Clin. Nurs."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bmjqs-2020-012786","article-title":"Is greater patient involvement associated with higher satisfaction? Experimental evidence from a vignette survey","volume":"31","author":"Birkeland","year":"2022","journal-title":"BMJ Qual. Saf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.pec.2022.03.012","article-title":"Shared decision making, patient-centered communication and patient satisfaction\u2013A cross-sectional analysis","volume":"105","author":"Siebinga","year":"2022","journal-title":"Patient Educ. Couns."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.6004\/jadpro.2023.14.3.3","article-title":"Uncovering and Addressing Implicit Bias in Oncology","volume":"14","author":"Dimarco","year":"2023","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100738","DOI":"10.1016\/j.adro.2021.100738","article-title":"Mitigating Implicit Bias in Radiation Oncology","volume":"6","author":"Diaz","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_68","first-page":"403","article-title":"From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care","volume":"5","author":"Guerra","year":"2021","journal-title":"JCO Precis. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/8\/1247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:37:44Z","timestamp":1777318664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/8\/1247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cancers18081247"],"URL":"https:\/\/doi.org\/10.3390\/cancers18081247","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}